Inclusion Criteria:
* ● Adults age 18-65 years at the time of enrollment
* Ability to stand for 10 minutes
* Presence of lumbosacral radicular pain within the past week that extends below the knee (i.e., pain radiating from the low back into the leg in a nerve root distribution) with or without accompanying low back pain, of at least 12 weeks' duration, AND
* Tampa Scale of Kinesiophobia score ≥ 23
* At least one positive physical examination finding consistent with lumbosacral radiculopathy, including at least one of the following:
* Positive straight leg raise test (eliciting radicular pain below the knee at ≤70 degrees of elevation);
* Positive Valsalva maneuver (eliciting radiculcar pain below the knee);
* Positive slump test;
* Neurological deficit in a lumbar nerve root distribution, including at least one of the following:
* Dermatomal sensory loss,
* Myotomal weakness, or
* Reduced or absent deep tendon reflexes (e.g., patellar or Achilles reflex) corresponding to the affected nerve root.
* Daily access to the internet via cell phone, tablet, or computer
* Willing to engage with Move-MORE 4-5 times per week on your own
* Willing to attend a two-hour-long virtual Zoom meeting once per week for eight weeks
* Willing to attend two in-person study visits and a follow-up visit
* Willing to complete 18 questionnaires pertaining to your pain symptoms, quality of life, psychosocial experiences, and your experiences in the trial
* Willing to wear an actigraphy device all day, every day, and while sleeping, for the duration of study participation and willing to keep it charged
* Willing to respond to a daily online survey for the duration of study participation
* Able to speak, read, and understand the English language
* Able to provide written informed consent
* Moderately motivated to participate as reported on a numeric rating scale (≥ 4/10)
Exclusion Criteria:
* ● Participants will be excluded if they have clinical signs or symptoms of lumbosacral radiculopathy with progressive neurologic deficits (loss of motor or sensory function) or intolerable pain.
* Participants with lumbosacral radiculopathy with progressive neurologic deficits will be referred for immediate medical attention, and are not eligible for participation in this study.
● Participants will be excluded if they have clinical signs or symptoms suggestive of cauda equina syndrome, including any of the following:
* New-onset urinary retention or overflow incontinence not attributable to other known causes;
* Fecal incontinence;
* New onset of saddle anesthesia (loss of sensation in the buttocks, perineum, and inner thighs);
* Severe or progressive bilateral lower extremity weakness;
* Participants with suspected cauda equina syndrome will be referred for immediate medical attention, and are not eligible for participation in this study.
* Presence of moderate to severe foot drop, defined as noticeable weakness in ankle dorsiflexion that interferes with walking or requires the use of an assistive device (e.g., ankle-foot orthosis). Participants with suspected or worsening foot drop will be referred for further evaluation and are not eligible for study participation.
* Current use of a spinal cord stimulator
* Have received epidural steroid injection in the prior 3 months
* Have received a surgical intervention for low back pain or lumbosacral radiculopathy in the previous 6 months
* Current active mindfulness meditation practice 1 time/week or more, and/or history of formal training in mindfulness/meditation practice
* Concurrent diagnosis of cancer
* Current unmanaged or uncontrolled mental illness known to cause psychosis: schizophrenia, schizotypal disorders, bipolar I disorder with psychosis, major depressive disorder with psychosis
* Diagnosis of Borderline Personality Disorder or score \>6 on the McLean Screening Instrument for Borderline Personality Disorder
* Initiation of or changes to an exercise regimen within 2 weeks prior to screening and/or enrollment
* Major medical or surgical event requiring hospitalization (for any reason other than a minor scheduled medical procedure) within 3 months prior to screening; or, scheduled or will be scheduled to occur within the 20 weeks (i.e., five months) after enrollment
* Currently participating in another interventional research study or participated in another interventional study within 2 weeks prior to screening
* Any reason the Clinical Investigator or Principal Investigator believes confers increased risk to the potential participant, if they were to enroll in the study
